ReviewFrontiers in oncology2023

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia.

Lili Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.